[Pharmacological studies of oxazolazepam, a new psychotropic agent. I. Actions on the central nervous system, especially on the behavioral aspect].
D000220:Adaptation, Biological / Q000187:drug effects; D000700:Analgesics; D000758:Anesthesia; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001362:Avoidance Learning / Q000187:drug effects; D001381:Azepines / Q000494:pharmacology* / Q000633:toxicity; D001522:Behavior, Animal / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D006224:Cricetinae; D003975:Diazepam / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D004361:Drug Tolerance; D004558:Electric Stimulation; D005260:Female; D006168:Guinea Pigs; D000882:Haplorhini; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013874:Thiopental; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014203:Tremorine / Q000037:antagonists & inhibitors
D000700:Analgesics; D000927:Anticonvulsants; D001381:Azepines; D010080:Oxazoles; D014149:Tranquilizing Agents; D002707:Chlordiazepoxide; D009020:Morphine; D013874:Thiopental; D001058:Apomorphine; D003975:Diazepam; D002746:Chlorpromazine; D014203:Tremorine